Gedea Biotech is a startup based in Sweden.
Gedea Biotech is a Swedish life science company developing pHyph, an antibiotic-free, CE-marked treatment for bacterial vaginosis that aims to restore and strengthen the vaginal microbiome. The company conducts clinical trials and is preparing commercialization of its product for pharmacies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.